G6PD and breast carcinoma: 6‐aminonicotinamide (6‐AN), an analogue of NADP that directly antagonizes G6PD activity, significantly decreased viability, colony formation capacity, and migration of breast cancer cells, leading to ROS upregulation and abnormal autophagy [56].